MASLD and MASH Coding Pocket Guide

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction–Associated Steatohepatitis (MASH)

Importance of Correct Coding in Laboratory Orders

Accurate coding in laboratory orders is crucial for the proper diagnosis and treatment of MASH/MASLD. Using incorrect ICD-10-CM diagnosis codes can result in insurance denials for testing coverage, shifting the financial responsibility to patients. With the strict reimbursement guidelines set by both public and private insurers for laboratory tests, it is essential that clinicians select ICD-10-CM codes with the highest level of specificity.

When ordering laboratory testing for MASH/MASLD, the clinician should consider the following, medically appropriate, codes as the reason for testing. Additionally, these codes should be documented and supported by the patient's medical record. It is also important that medical coders recognize when the Excludes1 and Excludes2 notes prevent the codes from being recognized by payers.

Diagnosis Codes for MASH/MASLD
 

ICD-10 Code Description
K74.00 - K74.69 Fibrosis and cirrhosis of the Liver
K75.81 or K75.89 K75.81 - Nonalcoholic steatophepatitis (NASH) and K78.89 - Other specified inflammatory liver disease
K76.0 Fatty (change of) liver, not elsewhere classified

Diagnosis Codes for Related Conditions That Support Further Investigation of the Patient’s Condition Which May Accompany the Diagnosis of MASH/MASLD

ICD-10 Code Description
I10 Essential (primary) hypertension
R74.8 Abnormal levels of other serum enzymes
R79.89 Other specified abnormal findings of blood chemistry

 

Support for this pocket guide provided in part by Siemens Healthineers